Merck & Co Inc. (NYSE:MRK) Enters License and Collaboration Agreement With Artiva Biotherapeutics for CAR-NK Therapies
Merck & Co Inc. (NYSE:MRK) has entered an exclusive global license and collaboration agreement with Artiva Biotherapeutics for the development
Read more